Eli Lilly and Company reported $65.179B in 2025 revenue and $20.640B in net income. The company is led by David A. Ricks and employed approximately 50,000 people at year-end 2025.
How Eli Lilly Makes Money
Lilly earns revenue from branded prescription medicines, with major growth from Mounjaro and Zepbound alongside oncology, immunology, neuroscience, and other therapies.
Latest Financial Snapshot
2025 revenue was $65.179B, and net income was $20.640B.
Why The Company Matters
Lilly matters because its obesity and diabetes medicines have reshaped pharmaceutical growth expectations and made manufacturing capacity a strategic advantage.
